These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 20505882

  • 1. Synthesis, molecular structure, and validation of metalloprobes for assessment of MDR1 P-glycoprotein-mediated functional transport.
    Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Sharma V.
    Dalton Trans; 2010 Jul 07; 39(25):5842-50. PubMed ID: 20505882
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
    Sharma V, Prior JL, Belinsky MG, Kruh GD, Piwnica-Worms D.
    J Nucl Med; 2005 Feb 07; 46(2):354-64. PubMed ID: 15695797
    [Abstract] [Full Text] [Related]

  • 3. Radiopharmaceuticals for assessment of multidrug resistance P-glycoprotein-mediated drug transport activity.
    Sharma V.
    Bioconjug Chem; 2004 Feb 07; 15(6):1464-74. PubMed ID: 15546216
    [Abstract] [Full Text] [Related]

  • 4. Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo.
    Sharma V, Beatty A, Wey SP, Dahlheimer J, Pica CM, Crankshaw CL, Bass L, Green MA, Welch MJ, Piwnica-Worms D.
    Chem Biol; 2000 May 07; 7(5):335-43. PubMed ID: 10801474
    [Abstract] [Full Text] [Related]

  • 5. Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases.
    Sivapackiam J, Gammon ST, Harpstrite SE, Sharma V.
    Methods Mol Biol; 2010 May 07; 596():141-81. PubMed ID: 19949924
    [Abstract] [Full Text] [Related]

  • 6. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
    Chen WS, Luker KE, Dahlheimer JL, Pica CM, Luker GD, Piwnica-Worms D.
    Biochem Pharmacol; 2000 Aug 01; 60(3):413-26. PubMed ID: 10856437
    [Abstract] [Full Text] [Related]

  • 7. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
    Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM.
    Cancer Res; 1993 Mar 01; 53(5):977-84. PubMed ID: 8094997
    [Abstract] [Full Text] [Related]

  • 8. Metalloprobes: Fluorescence imaging of multidrug resistance (MDR1) P-Glycoprotein (Pgp)-mediated functional transport activity in cellulo.
    Sundaram GS, Sharma M, Kaganov D, Cho J, Harpstrite SE, Sharma V.
    J Inorg Biochem; 2016 Jun 01; 159():159-64. PubMed ID: 27031494
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C, Grassi J, Demeule M, Fournier C, Boivin D, Béliveau R.
    Cancer Chemother Pharmacol; 2005 Aug 01; 56(2):173-81. PubMed ID: 15824923
    [Abstract] [Full Text] [Related]

  • 10. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
    Crankshaw CL, Marmion M, Luker GD, Rao V, Dahlheimer J, Burleigh BD, Webb E, Deutsch KF, Piwnica-Worms D.
    J Nucl Med; 1998 Jan 01; 39(1):77-86. PubMed ID: 9443741
    [Abstract] [Full Text] [Related]

  • 11. Metalloprobes: synthesis, characterization, and potency of a novel gallium(III) complex in human epidermal carcinoma cells.
    Harpstrite SE, Prior JL, Rath NP, Sharma V.
    J Inorg Biochem; 2007 Oct 01; 101(10):1347-53. PubMed ID: 17617464
    [Abstract] [Full Text] [Related]

  • 12. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, Schuetz EG.
    J Pharmacol Exp Ther; 2002 Oct 01; 303(1):323-32. PubMed ID: 12235267
    [Abstract] [Full Text] [Related]

  • 13. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB, Yan ML, Gong JP, Xia RP, Liu LX, Li N, Lu SC, Zhang JG, Zeng DB, Xie JG, Yang JY, Yan LN.
    Chin Med J (Engl); 2007 Apr 20; 120(8):703-7. PubMed ID: 17517188
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
    Kang DI, Kang HK, Gwak HS, Han HK, Lim SJ.
    Drug Deliv; 2009 Jul 20; 16(5):261-7. PubMed ID: 19538007
    [Abstract] [Full Text] [Related]

  • 19. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
    Luker GD, Rao VV, Crankshaw CL, Dahlheimer J, Piwnica-Worms D.
    Biochemistry; 1997 Nov 18; 36(46):14218-27. PubMed ID: 9369495
    [Abstract] [Full Text] [Related]

  • 20. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
    Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM.
    Biochemistry; 1998 Sep 29; 37(39):13660-73. PubMed ID: 9753453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.